Myocardial Perfusion Assessment With Multidetector Computed Tomography
Phase 3
- Conditions
- Coronary Artery Disease
- Registration Number
- NCT00846079
- Lead Sponsor
- Tennessee Heart and Vascular Institute, P.C.
- Brief Summary
Demonstrate the ability of muti-detector computed tomography to adequately perform stress testing will result in a veritable "one-stop shop" of non-invasive cardiac imaging that is, the ability to directly visualize heart arteries with high accuracy and to simultaniously determine the hemodynamic significance of any blockages visualized.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
- Adults >18 years of age
- Adults undergoing myocardial perfusion SPECT imaging
- Adults with suspected coronary artery disease
Exclusion Criteria
- Age <18
- Known or suspected renal insufficiency (Creatinine <1.7 mg/dl)
- Allergy to contrast
- Inability or contraindication to lexiscan or beta blocker
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Diagnostic Accuracy (Sensitivity/Specificity/Positive Predictive Value/Negative Predictive Value) 6 months
- Secondary Outcome Measures
Name Time Method Radiation dosimetry 6 months
Trial Locations
- Locations (1)
Tennessee Heart and Vascular Institute
🇺🇸Hendersonville, Tennessee, United States